Last reviewed · How we verify
Quadrivalent virosomal influenza vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Quadrivalent virosomal influenza vaccine (Quadrivalent virosomal influenza vaccine) — Crucell Holland BV.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Quadrivalent virosomal influenza vaccine TARGET | Quadrivalent virosomal influenza vaccine | Crucell Holland BV | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Quadrivalent virosomal influenza vaccine CI watch — RSS
- Quadrivalent virosomal influenza vaccine CI watch — Atom
- Quadrivalent virosomal influenza vaccine CI watch — JSON
- Quadrivalent virosomal influenza vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Quadrivalent virosomal influenza vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/quadrivalent-virosomal-influenza-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab